D. Visscher

发表

Microenvironmental Influences that Drive Progression from Benign Breast Disease to Invasive Breast Cancer

D. Radisky, Magdalena A. Cichon, A. Degnim, 2010, Journal of Mammary Gland Biology and Neoplasia.

Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer.

Greg Yothers, Peter A Kaufman, Norman Wolmark, 2005, The New England journal of medicine.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Archives of pathology & laboratory medicine.

American Society of Clinical Oncology/College of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer (unabridged version).

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Archives of pathology & laboratory medicine.

Clinicopathologic significance of p53 immunostaining in adenocarcinoma of the breast.

F. Sarkar, D. Visscher, J. Macoska, 1993, Archives of pathology & laboratory medicine.

The Spectrum of Columnar Cell Lesions

D. Visscher, T. D’alfonso, Timothy D’alfonso, 2016 .

Lobular neoplasia: how to manage with partial understanding.

L. Hartmann, D. Visscher, 2011, Oncology.

Breast cancer risk in women with radial scars in benign breast biopsies

R. Vierkant, C. Vachon, K. Brandt, 2008, Breast Cancer Research and Treatment.

Proliferative and Preneoplastic Lesions of the Breast

D. Visscher, 2014 .

Flat epithelial atypia and risk of breast cancer: A Mayo cohort study

Karthik Ghosh, R. Vierkant, D. Radisky, 2015, Cancer.

Genetic markers as prognostic indicators in breast cancer

F. Sarkar, D. Visscher, S. Wolman, 1992, Cancer.

Histologic spectrum of idiopathic interstitial pneumonias.

D. Visscher, J. Myers, J. Myers, 2006, Proceedings of the American Thoracic Society.

Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer.

Jeremy Chien, Marina Bibikova, Sebastian M. Armasu, 2014, Cancer research.

Pharmacogenetics of tamoxifen biotransformation is associated with clinical outcomes of efficacy and hot flashes.

Fergus J Couch, Zeruesenay Desta, David A Flockhart, 2005, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Two concurrent phase II trials of paclitaxel/carboplatin/trastuzumab (weekly or every-3-week schedule) as first-line therapy in women with HER2-overexpressing metastatic breast cancer: NCCTG study 983252.

E. Perez, D. Visscher, J. Ingle, 2005, Clinical breast cancer.

Photodynamic Therapy for Treatment of AIDS-Related Oral Kaposi's Sarcoma

D. Visscher, V. Schweitzer, 1990, Otolaryngology--head and neck surgery : official journal of American Academy of Otolaryngology-Head and Neck Surgery.

Ki67: a time-varying biomarker of risk of breast cancer in atypical hyperplasia

R. Vierkant, V. Pankratz, L. Hartmann, 2010, Breast Cancer Research and Treatment.

A phase 1 and pharmacodynamic study of chronically-dosed, single-agent veliparib (ABT-888) in patients with BRCA1- or BRCA2-mutated cancer or platinum-refractory ovarian or triple-negative breast cancer

D. Visscher, A. Chen, E. Swisher, 2022, Cancer Chemotherapy and Pharmacology.

Immunohistologic evaluation of invasion-associated proteases in breast carcinoma.

F. Sarkar, D. Visscher, W. Sakr, 1993, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Human cancer: Molecular genetic and viral concepts and their influence in cytodiagnosis

F. Sarkar, G. Nuovo, D. Visscher, 1993 .

Systemic treatment with interleukin-4 induces regression of pulmonary metastases in a murine renal cell carcinoma model.

G. Haas, J. Lam, R. Puri, 1995, Cellular immunology.

INTRALESIONAL TREATMENT OF ESTABLISHED MURINE PRIMARY PRIMARY TUMOR WITH NO IMPACT ON METASTASES RENAL TUMOR WITH INTERLEUKIN-4: LOCALIZED EFFECT ON

G. Haas, R. Puri, D. Visscher, 1995 .

Intralesional treatment of established murine primary renal tumor with interleukin-4: localized effect on primary tumor with no impact on metastases.

G. Haas, R. Puri, D. Visscher, 1995, The Journal of urology.

Two-color multiparametric method for flow cytometric DNA analysis of carcinomas using staining for cytokeratin and leukocyte-common antigen.

D. Visscher, R. Zarbo, J. Crissman, 1989, Analytical and quantitative cytology and histology.

Multiparametric deoxyribonucleic acid and cell cycle analysis of breast carcinomas by flow cytometry. Clinicopathologic correlations.

D. Visscher, R. Zarbo, W. Sakr, 1990, Laboratory investigation; a journal of technical methods and pathology.

Multiparametric evaluation of flow cytometric synthesis phase fraction determination in dual-labelled breast carcinomas.

D. Visscher, R. Zarbo, J. Crissman, 1991, Analytical and quantitative cytology and histology.

Epigenome-wide ovarian cancer analysis identifies a methylation profile differentiating clear-cell histology with epigenetic silencing of the HERG K+ channel.

Sebastian M. Armasu, David N. Rider, R. Vierkant, 2013, Human molecular genetics.

Determination of Her-2/Neu Status in Breast Carcinoma: Comparative Analysis of Immunohistochemistry and Fluorescent In Situ Hybridization

D. Visscher, R. Jimenez, T. Wallis, 2000, Modern Pathology.

Histopathologic Analysis of Atypical Lesions in Image-Guided Core Breast Biopsies

D. Visscher, N. Pernick, M. Bonnett, 2003, Modern Pathology.

Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer.

E. Perez, D. Visscher, J. Ingle, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

p16INK4a Expression and Breast Cancer Risk in Women with Atypical Hyperplasia

R. Vierkant, V. Pankratz, D. Radisky, 2011, Cancer Prevention Research.

Sinonasal Schneiderian papillomas: human papillomavirus typing by polymerase chain reaction.

F. Sarkar, D. Visscher, R. Zarbo, 1992, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Gene expression profiling identifies responsive patients with cancer of unknown primary treated with carboplatin, paclitaxel, and everolimus: NCCTG N0871 (alliance).

D. Visscher, M. Goetz, N. Foster, 2016, Annals of oncology : official journal of the European Society for Medical Oncology.

Gene expression pro fi ling identi fi es responsive patients with cancer of unknown primary treated with carboplatin , paclitaxel , and everolimus : NCCTG N 0871 ( alliance ) †

D. Visscher, M. Goetz, N. Foster, 2016 .

Cystathionine Beta-Synthase (CBS) Contributes to Advanced Ovarian Cancer Progression and Drug Resistance

A. Weaver, D. Visscher, A. Sood, 2013, PloS one.

Macrophagic “Crown-like Structures” Are Associated with an Increased Risk of Breast Cancer in Benign Breast Disease

D. Radisky, A. Degnim, D. Visscher, 2017, Cancer Prevention Research.

Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients

Gretchen L. Gierach, D. Radisky, M. García-Closas, 2017, Breast Cancer Research.

Spontaneous murine tumors in the development of patient-derived xenografts: a potential pitfall

R. Weinshilboum, Liewei Wang, D. Visscher, 2019, Oncotarget.

Haploid transcripts persist in mature human spermatozoa.

S. Krawetz, D. Visscher, S. Wykes, 1997, Molecular human reproduction.

Genomics, histopathology, and the tumor microenvironment: new relationship or old friends re-discovered?

D. Visscher, 2011, Breast Cancer Research and Treatment.

Assessment of folate receptor alpha and beta expression in selection of lung and pancreatic cancer patients for receptor targeted therapies

P. Low, D. Visscher, S. Singhal, 2017, Oncotarget.

Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

Francesmary Modugno, Christine Chow, Ellen L Goode, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Clinicopathologic analysis of k-ras, p53, and ERBB-2 gene alterations in pulmonary adenocarcinoma.

F. Sarkar, D. Visscher, P. Tabaczka, 1997, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Diagnosis and management of benign, atypical, and indeterminate breast lesions detected on core needle biopsy.

D. Visscher, D. Wahner-Roedler, K. Glazebrook, 2014, Mayo Clinic proceedings.

Ductal carcinoma in situ in African American versus Caucasian American women

D. Visscher, K. Visvanathan, H. Nassar, 2009, Cancer.

Impact of breast carcinoma on African‐American women

L. Newman, D. Visscher, M. Simon, 2001, Cancer.

Benign Breast Disease and the Risk of Subsequent Breast Cancer in African American Women

D. Radisky, L. Hartmann, D. Visscher, 2012, Cancer Prevention Research.

What values are critical?

D. Visscher, 2008, American journal of clinical pathology.

American Society of Clinical Oncology/College Of American Pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

Anthony Rhodes, Paul Valenstein, Keith Miller, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

HER2 testing by local, central, and reference laboratories in the NCCTG N9831 Intergroup Adjuvant Trial.

E. Perez, S. Martino, D. Visscher, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Ductal Carcinoma In Situ in African

D. Visscher, K. Visvanathan, H. Nassar, 2009 .

ERβ Expression and Breast Cancer Risk Prediction for Women with Atypias

D. Radisky, L. Hartmann, A. Degnim, 2015, Cancer Prevention Research.

Neuroendocrine Tumors of the Breast

D. Visscher, Saba Yasir, 2017, Endocrine Pathology.

Papillary and Adenomyoepithelial Tumors

D. Visscher, T. D’alfonso, Sandra J Shin, 2016 .

Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype

C. Vachon, C. Scott, K. Brandt, 2019, Breast Cancer Research.

Neuroendocrine differentiation in poorly differentiated lung carcinomas: a light microscopic and immunohistologic study.

D. Visscher, R. Zarbo, W. Sakr, 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Geographic distribution of co-dominant DNA stemlines in breast carcinoma.

D. Visscher, J. Crissman, S. Ottosen, 1995, Cytometry.

Breast implant capsule-associated squamous cell carcinoma: a report of 2 cases.

D. Visscher, J. Carter, G. Keeney, 2017, Human pathology.

Regional Differences in Breast Cancer Biomarkers in American Indian and Alaska Native Women

R. Vierkant, D. Visscher, T. Hobday, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Estrogen Receptor Expression in Atypical Hyperplasia: Lack of Association with Breast Cancer

R. Vierkant, D. Radisky, L. Hartmann, 2011, Cancer Prevention Research.

Influence of Lactation History on Breast Nipple Aspirate Fluid Yields and Fluid Composition

D. Visscher, Z. Djuric, L. Heilbrun, 2005, The breast journal.

Histopathologic parameters and DNA analysis in colorectal adenocarcinomas.

C. Ma, D. Visscher, R. Zarbo, 1989, Pathology annual.

Understanding the Premalignant Potential of Atypical Hyperplasia through Its Natural History: A Longitudinal Cohort Study

Derek C. Radisky, Marlene H. Frost, Karthik Ghosh, 2014, Cancer Prevention Research.

Breast Cancer Risk and Use of Nonsteroidal Anti-inflammatory Agents After a Benign Breast Biopsy

R. Vierkant, C. Vachon, M. Jensen, 2020, Cancer Prevention Research.

Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.

G. Haas, J. Lam, R. Puri, 1997, Clinical cancer research : an official journal of the American Association for Cancer Research.

Hyaline fibrous involution of breast lobules: a histologic finding associated with germline BRCA mutation

D. Radisky, A. Degnim, D. Visscher, 2019, Modern Pathology.

Tumor hypomethylation at 6p21.3 associates with longer time to recurrence of high-grade serous epithelial ovarian cancer.

B. Fridley, E. Goode, L. Hartmann, 2014, Cancer Research.

Ages at menarche- and menopause-related genetic variants in relation to terminal duct lobular unit involution in normal breast tissue

Gretchen L. Gierach, S. Chanock, M. García-Closas, 2016, Breast Cancer Research and Treatment.

Cytotoxic T cell depletion with increasing epithelial abnormality in women with benign breast disease

D. Radisky, A. Degnim, D. Visscher, 2020, Breast Cancer Research and Treatment.

Histopathologic analysis of chromosome aneuploidy in ductal carcinoma in situ.

D. Visscher, R. Jimenez, T. Wallis, 2000, Human pathology.

In reply [2]

F. Couch, E. Perez, D. Visscher, 2006 .

Diagnosis of pulmonary infection caused by Aspergillus: usefulness of respiratory cultures.

D. Visscher, J. Smith, M. Bartlett, 1985, The Journal of infectious diseases.

Anomalous cytokeratin expression in malignant melanoma: one- and two-dimensional western blot analysis and immunohistochemical survey of 100 melanomas.

A. Gown, D. Visscher, R. Zarbo, 1990, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Clinicopathologic analysis of breast lesions associated with multiple papillomas.

D. Visscher, R. Ali-Fehmi, T. Wallis, 2003, Human pathology.

Immunohistologic analysis of invasive phenotype in breast carcinoma. A clinicopathologic study.

F. Sarkar, D. Visscher, W. Sakr, 1993, Pathology, research and practice.

Histopathologic and Flow-Cytometric Analysis of Neoplastic and Benign “background” Tissue in Breast Carcinoma Resections

D. Visscher, J. Crissman, P. Tabaczka, 1998, Analytical cellular pathology : the journal of the European Society for Analytical Cellular Pathology.

A multivariate model to predict cancer upgrade from atypical ductal hyperplasia by core needle biopsy.

A. Degnim, D. Visscher, J. Boughey, 2014, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Molecular genetic analysis in the pathologic evaluation of solid tumors: Theory and practice

F. Sarkar, D. Visscher, J. Crissman, 1997, Journal of clinical laboratory analysis.

Galectin-3 and L1 retrotransposons in human breast carcinomas

F. Sarkar, D. Visscher, A. Raz, 1998, Breast Cancer Research and Treatment.

Pulmonary veno-occlusive disease as a primary cause of pulmonary hypertension in a patient with mixed connective tissue disease

D. Visscher, M. Aubry, C. Rihal, 2007, Rheumatology International.

First-in-Human Phase I Study of the Tamoxifen Metabolite Z-Endoxifen in Women With Endocrine-Refractory Metastatic Breast Cancer.

M. A. Mahr, Minetta C. Liu, D. Visscher, 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Maspin expression inversely correlates with breast tumor progression in MMTV/TGF-alpha transgenic mouse model

S. Sheng, D. Visscher, K. Reddy, 2001, Oncogene.

Association between cyclooxygenase-2 expression in atypical hyperplasia and risk of breast cancer.

R. Vierkant, V. Pankratz, L. Hartmann, 2008, Journal of the National Cancer Institute.

Cytochrome P450 2D6 status predicts breast cancer relapse in women receiving adjuvant tamoxifen (Tam).

E. Perez, D. Visscher, M. Goetz, 2006, Journal of Clinical Oncology.

HER2 testing by local, central, and reference laboratories in specimens from the North Central Cancer Treatment Group N9831 intergroup adjuvant trial.

Peter A Kaufman, James N Ingle, Edith A Perez, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Analysis of intratumoral heterogeneity and amplification status in breast carcinomas with equivocal (2+) HER-2 immunostaining.

D. Visscher, C. Reynolds, R. Jenkins, 2005, American journal of clinical pathology.

Evaluation of MYC and chromosome 8 copy number in breast carcinoma by interphase cytogenetics

D. Visscher, J. Crissman, A. Mohamed, 1997, Genes, chromosomes & cancer.

Correlation Between p53 Immunostaining Patterns and Gene Sequence Mutations in Breast Carcinoma

F. Sarkar, D. Visscher, J. Crissman, 1996, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Biomarkers of Proliferative Breast Disease

D. Visscher, 1995 .

Interaction of transforming growth factor‐alpha and epidermal growth factor receptor in breast carcinoma. An immunohistologic study

F. Sarkar, D. Visscher, J. Crissman, 1994, Cancer.

The clinicopathologic significance of genetic instability in breast carcinoma progression

D. Visscher, S. Wykes, 1999 .

Significant histologic features differentiating cellular fibroadenoma from phyllodes tumor on core needle biopsy specimens.

D. Visscher, A. Nassar, S. Jenkins, 2014, American journal of clinical pathology.

Premalignant lesions of the upper aerodigestive tract: Pathologic classification

D. Visscher, J. Crissman, W. Sakr, 1993, Journal of cellular biochemistry. Supplement.

Pseudoangiomatous Stromal Hyperplasia and Breast Cancer Risk

R. Vierkant, D. Radisky, L. Hartmann, 2010, Annals of Surgical Oncology.

Clear Cell Tumor of the Lung. A Clinicopathologic, Immunohistochemical, and Ultrastructural Study of Eight Cases

M. Gaffey, D. Visscher, F. Askin, 1990, The American journal of surgical pathology.

Enhanced expression of tissue inhibitor of metalloproteinase‐2 (TIMP‐2) in the stroma of breast carcinomas correlates with tumor recurrence

F. Sarkar, D. Visscher, C. Liang, 1994, International journal of cancer.

Cellular fibroepithelial lesions of the breast: A long term follow up study.

L. Hartmann, A. Degnim, D. Visscher, 2018, Annals of diagnostic pathology.

Clinicopathologic significance of cathepsin B immunostaining in transitional neoplasia.

Bonnie F. Sloane, D. Visscher, J. Crissman, 1994, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Concurrent abnormal expression of ERBB-2, EGFR, and p53 genes and clinical disease progression of breast carcinoma

F. Sarkar, D. Visscher, S. Wykes, 2004, Breast Cancer Research and Treatment.

Pathologic analysis of tumor size and lymph node status in multifocal/multicentric breast carcinoma

David Bouwman, Jyotirmoy Dey, L. Newman, 2002, Cancer.

Direct action of estrogen on sequence of progression of human preneoplastic breast disease.

D. Visscher, M. Shekhar, P. Nangia-Makker, 1998, The American journal of pathology.

Multivariate model to identify women at low risk of cancer upgrade after a core needle biopsy diagnosis of atypical ductal hyperplasia

Robert T. Fazzio, A. Degnim, D. Visscher, 2017, Breast Cancer Research and Treatment.

Extent of atypical hyperplasia stratifies breast cancer risk in 2 independent cohorts of women

R. Vierkant, C. Vachon, D. Radisky, 2016, Cancer.

Immune cells are increased in normal breast tissues of BRCA1/2 mutation carriers

D. Radisky, A. Degnim, D. Visscher, 2022, Breast Cancer Research and Treatment.

Idiopathic bronchiolitis obliterans with organizing pneumonia. An acute and life-threatening syndrome.

D. Visscher, I. Nizami, B. Dubaybo, 1995, Chest.

Quantitative Analysis of Her‐2/neu (ERBB2) Gene Expression Using Reverse Transcriptase Polymerase Chain Reaction

F. Sarkar, D. Visscher, J. Crissman, 1993, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Assessment of folate receptor-β expression in human neoplastic tissues

P. Low, D. Dimitrov, D. Visscher, 2015, Oncotarget.

Clinicopathologic and interphase cytogenetic analysis of papillary (chromophilic) renal cell carcinoma.

D. Grignon, G. Haas, D. Visscher, 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Endometrioid Endometrial Carcinoma With Atrophic Endometrium and Poor Prognosis

D. Visscher, J. Pijnenborg, S. Dowdy, 2012, Obstetrics and gynecology.

Premalignant lesions of the upper aerodigestive tract: Biomarkers of genetic alterations, proliferation, and differentiation

F. Sarkar, D. Visscher, J. Crissman, 1993, Journal of cellular biochemistry. Supplement.

Clinicopathologic analysis of amphiregulin and heregulin immunostaining in breast neoplasia

F. Sarkar, D. Visscher, K. Reddy, 1997, Breast Cancer Research and Treatment.

Comparison of PCNA/cyclin immunohistochemistry with flow cytometric S-phase fraction in breast cancer

D. Visscher, J. Crissman, S. Wykes, 2005, Breast Cancer Research and Treatment.

Flow Cytometric Proliferative Fraction Analysis in Solid Tumors

D. Visscher, J. Crissman, S. Wykes, 1996 .

Bronchiolitis: the pathologist's perspective.

D. Visscher, J. Myers, J. Myers, 2006, Proceedings of the American Thoracic Society.

Biologic and clinical significance of basic fibroblast growth factor immunostaining in breast carcinoma.

F. Sarkar, D. Visscher, J. Crissman, 1995, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Bone Erosion in Allergic Fungal Sinusitis

D. Visscher, A. Katzenstein, G. Peters, 1990 .

Analysis of chromosome aneuploidy in breast carcinoma progression by using fluorescence in situ hybridization.

D. Visscher, T. Wallis, J. Mendelin, 1999, Laboratory investigation; a journal of technical methods and pathology.

Squamous cell carcinoma of the buccal mucosa: analysis of prognostic factors.

C. O'brien, D. Visscher, S. Soong, 1987, American journal of surgery.

Cutaneous neuroendocrine (Merkel cell) carcinoma: an immunophenotypic, clinicopathologic, and flow cytometric study.

D. Visscher, R. Zarbo, J. Crissman, 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Complex fibroadenoma and breast cancer risk: a Mayo Clinic Benign Breast Disease Cohort Study

R. Vierkant, C. Vachon, D. Radisky, 2015, Breast Cancer Research and Treatment.

Benign breast disease and the risk of breast cancer.

V Shane Pankratz, Celine M Vachon, Thomas A Sellers, 2005, The New England journal of medicine.

Chromosomal aneuploidy in proliferative breast disease.

D. Visscher, S. Gulino, S. Wolman, 1994, Human pathology.

Increased ERBB2 Gene Copy Numbers Reveal a Subset of Salivary Duct Carcinomas with High Densities of Tumor Infiltrating Lymphocytes and PD-L1 Expression

D. Visscher, M. Rivera, P. Greipp, 2020, Head and Neck Pathology.

Performance of automated scoring of ER, PR, HER2, CK5/6 and EGFR in breast cancer tissue microarrays in the Breast Cancer Association Consortium

Päivi Heikkilä, Carlos Caldas, Arto Mannermaa, 2014, The journal of pathology. Clinical research.

Non-BRCA familial breast cancer: review of reported pathology and molecular findings.

F. Couch, D. Visscher, N. Lindor, 2017, Pathology.

Cellular Genetic Alterations: Models of Breast and Colon Cancer

D. Visscher, S. Wolman, 1993 .

Image cytophotometric DNA analysis of atypical hyperplasias and intraductal carcinomas of the breast.

D. Visscher, J. Crissman, J. Kubus, 1990, Archives of pathology & laboratory medicine.

Invasive Micropapillary Salivary Duct Carcinoma: A Distinct Histologic Variant With Biologic Significance

D. Visscher, T. Nagao, H. Minato, 2004, The American journal of surgical pathology.

Update on selected salivary gland neoplasms.

D. Visscher, J. Mchugh, E. Barnes, 2009, Archives of pathology & laboratory medicine.

Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Krishna R. Kalari, Kevin J. Thompson, A. Schweitzer, 2017, Breast Cancer Research.

A clinical calculator to predict disease outcomes in women with triple-negative breast cancer

F. Couch, S. Leung, T. Nielsen, 2021, Breast Cancer Research and Treatment.

53BP1 as a potential predictor of response in PARP inhibitor-treated homologous recombination-deficient ovarian cancer.

A. Oberg, D. Visscher, A. Jager, 2019, Gynecologic oncology.

The impact of cytochrome P450 2D6 metabolism in women receiving adjuvant tamoxifen

David A. Flockhart, Richard M. Weinshilboum, Fergus J. Couch, 2006, Breast Cancer Research and Treatment.

DNA methyltransferase expression in triple-negative breast cancer predicts sensitivity to decitabine

Krishna R. Kalari, K. Kalari, S. Mclaughlin, 2018, The Journal of clinical investigation.

Antiintegrin alpha v beta 3 blocks human breast cancer growth and angiogenesis in human skin.

F. Sarkar, D. Visscher, R. Klemke, 1995, The Journal of clinical investigation.

Flow cytometric DNA analysis of fresh prostatic resections: Correlation with conventional prognostic parameters in patients with prostate cancer

G. Haas, D. Visscher, W. Sakr, 1993, Cancer.

Correction to: Establishing and characterizing patient-derived xenografts using pre-chemotherapy percutaneous biopsy and post-chemotherapy surgical samples from a prospective neoadjuvant breast cancer study

Kevin J. Thompson, K. Kalari, S. Mclaughlin, 2021, Breast Cancer Research.

Tumor Sequencing and Patient-Derived Xenografts in the Neoadjuvant Treatment of Breast Cancer

Krishna R. Kalari, Kevin J. Thompson, K. Kalari, 2017, Journal of the National Cancer Institute.

Exome sequencing reveals frequent deleterious germline variants in cancer susceptibility genes in women with invasive breast cancer undergoing neoadjuvant chemotherapy

Ann M. Moyer, Steven N. Hart, Krishna R. Kalari, 2015, Breast Cancer Research and Treatment.

Tamoxifen Suppresses Histologic Progression to Atypia and DCIS in MCFIOAT Xenografts, a Model of Early Human Breast Cancer

D. Visscher, G. Heppner, P. Shekhar, 2004, Breast Cancer Research and Treatment.

Annexin A1 expression in a pooled breast cancer series: association with tumor subtypes and prognosis

Jaana M. Hartikainen, C. Vachon, J. Olson, 2015, BMC Medicine.

Annexin A 1 expression in a pooled breast cancer series

C. Vachon, J. Olson, F. Couch, 2022 .

The Ratios of CD8+ T Cells to CD4+CD25+ FOXP3+ and FOXP3- T Cells Correlate with Poor Clinical Outcome in Human Serous Ovarian Cancer

Claudia C. Preston, E. Goode, A. Oberg, 2013, PloS one.

Association of mammographic density measures and breast cancer “intrinsic” molecular subtypes

S. Cummings, C. Vachon, C. Scott, 2021, Breast Cancer Research and Treatment.

Pathology of breast Cancer in the last half century.

D. Visscher, M. Solanki, 2019, Human pathology.

Atypical apocrine adenosis of the breast: long-term follow-up in 37 patients.

R. Vierkant, L. Hartmann, A. Degnim, 2012, Archives of pathology & laboratory medicine.

Apocrine ductal carcinoma in situ involving a sclerosing lesion with adenosis: report of a case.

D. Visscher, 2009, Archives of pathology & laboratory medicine.

Signals from the Metastatic Niche Regulate Early and Advanced Ovarian Cancer Metastasis through miR-4454 Downregulation

D. Visscher, A. Mariani, F. Multinu, 2020, Molecular Cancer Research.

Ki-67 expression in sclerosing adenosis and adjacent normal breast terminal ductal lobular units: a nested case–control study from the Mayo Benign Breast Disease Cohort

R. Vierkant, D. Radisky, L. Hartmann, 2015, Breast Cancer Research and Treatment.

Dense and Nondense Mammographic Area and Risk of Breast Cancer by Age and Tumor Characteristics

Andrew H. Beck, S. Cummings, C. Vachon, 2015, Cancer Epidemiology, Biomarkers & Prevention.

Tissue composition of mammographically dense and non-dense breast tissue

Derek C. Radisky, James N. Ingle, Kathleen R. Brandt, 2011, Breast Cancer Research and Treatment.

Comedo-Ductal carcinoma in situ: A paradoxical role for programmed cell death

D. Visscher, Gen Sheng Wu, M. Shekhar, 2008, Cancer biology & therapy.

Terminal duct lobular unit involution of the normal breast: implications for breast cancer etiology.

Gretchen L. Gierach, M. Sherman, A. Degnim, 2014, Journal of the National Cancer Institute.

Independent Association of Lobular Involution and Mammographic Breast Density With Breast Cancer Risk

R. Vierkant, C. Vachon, K. Brandt, 2010, Journal of the National Cancer Institute.

Association between mammographic density and age-related lobular involution of the breast.

V Shane Pankratz, Celine M Vachon, Thomas A Sellers, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Evaluation of chromosome aneuploidy in tissue sections of preinvasive breast carcinomas using interphase cytogenetics

D. Visscher, J. Crissman, T. Wallis, 1996, Cancer.

Prognostic significance of morphological parameters and flow cytometric DNA analysis in carcinoma of the breast.

D. Visscher, R. Zarbo, J. Crissman, 1990, Pathology annual.

Prevention of Human Lymphoproliferative Tumor Formation in Ovarian Cancer Patient-Derived Xenografts12

D. Visscher, S. Weroha, P. Haluska, 2017, Neoplasia.

An Analysis of Breast Cancer Risk in Women With Single, Multiple, and Atypical Papilloma

R. Vierkant, L. Hartmann, D. Visscher, 2006, The American journal of surgical pathology.

Proliferative disease and atypia in biopsies performed for nonpalpable lesions detected mammographically

D. Visscher, M. Urist, E. Rubin, 1988, Cancer.

Utilizing Nottingham Prognostic Index in microarray gene expression profiling of breast carcinomas

F. Couch, E. Perez, D. Visscher, 2004, Modern Pathology.

HER2 and chromosome 17 effect on patient outcome in the N9831 adjuvant trastuzumab trial.

E. Perez, S. Martino, G. Sledge, 2010, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Stratification of breast cancer risk in women with atypia: a Mayo cohort study.

R. Vierkant, T. Sellers, L. Melton, 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Lysine 394 is a novel Rad6B-induced ubiquitination site on beta-catenin.

D. Visscher, M. Shekhar, L. Tait, 2012, Biochimica et biophysica acta.

Clinicopathologic Analysis of Invasive Micropapillary Differentiation in Breast Carcinoma

D. Visscher, J. Dey, V. Adsay, 2001, Modern Pathology.

Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression

D. Radisky, D. Visscher, G. Downey, 2012, Science Translational Medicine.

Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

Jane E. Carpenter, Kristen S Purrington, Victoria L. Cafourek, 2014, Carcinogenesis.

Metaplastic breast cancer has a poor response to neoadjuvant systemic therapy

D. Visscher, M. Goetz, J. Ingle, 2019, Breast cancer research and treatment.

Histologic findings in normal breast tissues: comparison to reduction mammaplasty and benign breast disease tissues

R. Vierkant, C. Vachon, D. Radisky, 2012, Breast Cancer Research and Treatment.

Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia.

R. Vierkant, C. Vachon, V. Pankratz, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort

R. Vierkant, C. Vachon, C. Scott, 2017, BMC Cancer.

Genes associated with bowel metastases in ovarian cancer.

E. Goode, A. Oberg, L. Hartmann, 2019, Gynecologic oncology.

Significance of crystalline inclusions in lung granulomas.

D. Visscher, A. Churg, A. Katzenstein, 1988, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Pathological and biological relevance of cytophotometric DNA content to breast carcinoma genetic progression

D. Visscher, J. Crissman, M. Micale, 1993, Journal of cellular biochemistry. Supplement.

Coordinate expression of the PRM1, PRM2, and TNP2 multigene locus in human testis.

S. Krawetz, D. Visscher, D. Djakiew, 1995, DNA and cell biology.

Folate Receptor Alpha Peptide Vaccine Generates Immunity in Breast and Ovarian Cancer Patients

A. Dietz, D. Visscher, T. Hobday, 2018, Clinical Cancer Research.

Clinicopathologic Analysis of Fas, Fas Ligand, and Other Biomarkers in Locally Advanced Breast Carcinoma

D. Visscher, N. Pernick, W. Du, 2000, The breast journal.

Management of Benign Intraductal Solitary Papilloma Diagnosed on Core Needle Biopsy

Carol Reynolds, Katrina N. Glazebrook, D. Visscher, 2013, Annals of Surgical Oncology.

Epithelioid Inflammatory Myofibroblastic Sarcoma of the Ovary With RANB2-ALK Fusion: Report of a Case.

A. Folpe, D. Visscher, J. K. Schoolmeester, 2017, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

CD56+ immune cell infiltration and MICA are decreased in breast lobules with fibrocystic changes

D. Radisky, A. Degnim, D. Visscher, 2017, Breast Cancer Research and Treatment.

Standardized measures of lobular involution and subsequent breast cancer risk among women with benign breast disease: a nested case–control study

Gretchen L. Gierach, D. Radisky, L. Hartmann, 2016, Breast Cancer Research and Treatment.

Natural history of age-related lobular involution and impact on breast cancer risk

R. Vierkant, C. Vachon, D. Radisky, 2016, Breast Cancer Research and Treatment.

Novel breast tissue feature strongly associated with risk of breast cancer.

R. Vierkant, C. Vachon, V. Pankratz, 2009, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Romayne A. Thompson, R. Vierkant, T. Sellers, 2006, Journal of the National Cancer Institute.

Interaction of mammographic breast density with menopausal status and postmenopausal hormone use in relation to the risk of aggressive breast cancer subtypes

Andrew H. Beck, S. Cummings, C. Vachon, 2017, Breast Cancer Research and Treatment.

Adenocarcinoma of the rete testis with a spindle cell component. A possible metaplastic carcinoma

D. Visscher, A. Talerman, M. Mazur, 1989, Cancer.

Clinicopathologic Analysis of Solid Papillary Carcinoma of the Breast and Associated Invasive Carcinomas

D. Visscher, H. Qureshi, H. Nassar, 2006, The American journal of surgical pathology.

A Two-Gene Expression Ratio of Homeobox 13 and Interleukin-17B Receptor for Prediction of Recurrence and Survival in Women Receiving Adjuvant Tamoxifen

F. Couch, E. Perez, Xiao-Jun Ma, 2006, Clinical Cancer Research.

Breast cancer and aneusomy 17: implications for carcinogenesis and therapeutic response.

E. Perez, D. Visscher, W. Lingle, 2009, The Lancet. Oncology.

Immune cell quantitation in normal breast tissue lobules with and without lobulitis

Derek C. Radisky, Rushin D. Brahmbhatt, Aaron Mansfield, 2014, Breast Cancer Research and Treatment.

Evaluation of 2 breast cancer risk models in a benign breast disease cohort

R. Vierkant, C. Vachon, K. Brandt, 2018, Cancer.

Nutritional predictors for cellular nipple aspirate fluid: Nutrition and Breast Health Study

D. Visscher, Z. Djuric, I. Kato, 2006, Breast Cancer Research and Treatment.

Automated quantification of levels of breast terminal duct lobular (TDLU) involution using deep learning

R. Vierkant, G. Litjens, J. A. van der Laak, 2022, NPJ breast cancer.

Relationship between crown-like structures and sex-steroid hormones in breast adipose tissue and serum among postmenopausal breast cancer patients

D. Radisky, M. García-Closas, L. Hartmann, 2017, Breast Cancer Research.

Mucocele-like lesions of the breast: a clinical outcome and histologic analysis of 102 cases.

R. Vierkant, L. Hartmann, A. Degnim, 2016, Human pathology.

Model for individualized prediction of breast cancer risk after a benign breast biopsy.

V Shane Pankratz, Celine M Vachon, Karthik Ghosh, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Association between mammographic breast density and histologic features of benign breast disease

R. Vierkant, C. Vachon, C. Scott, 2017, Breast Cancer Research.

Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease

D. Visscher, J. Ruterbusch, S. Bandyopadhyay, 2018, Breast Cancer Research.

Clinicopathologic analysis of macrophage infiltrates in breast carcinoma.

D. Long, D. Visscher, J. Crissman, 1995, Pathology, research and practice.

Alterations in the Immune Cell Composition in Premalignant Breast Tissue that Precede Breast Cancer Development

C. Vachon, D. Radisky, A. Degnim, 2017, Clinical Cancer Research.

Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

Kristen S Purrington, S. Cross, C. Vachon, 2016, Breast Cancer Research and Treatment.

Rad6 overexpression induces multinucleation, centrosome amplification, abnormal mitosis, aneuploidy, and transformation.

H. Heng, D. Visscher, A. Lyakhovich, 2002, Cancer research.

CHFR and Paclitaxel Sensitivity of Ovarian Cancer

A. Oberg, D. Visscher, K. Flatten, 2021, Cancers.

Pregnancy-associated plasma protein-A expression in human breast cancer.

D. Visscher, A. Mansfield, M. Goetz, 2014, Growth hormone & IGF research : official journal of the Growth Hormone Research Society and the International IGF Research Society.

Prognostic significance of image morphometric microvessel enumeration in breast carcinoma.

D. Visscher, S. Wykes, S. Drozdowicz, 1993, Analytical and quantitative cytology and histology.

Tissue-based associations of mammographic breast density with breast stem cell markers

C. Vachon, C. Scott, KathleenR. Brandt, 2017, Breast Cancer Research.

Mammographic density and risk of breast cancer by age and tumor characteristics

Andrew H. Beck, Karla Kerlikowske, Bo Fan, 2013, Breast Cancer Research.

Immunohistochemical and genetic profiles of endometrioid endometrial carcinoma arising from atrophic endometrium.

D. Visscher, E. Zwarthoff, J. Pijnenborg, 2015, Gynecologic oncology.

Running title: Mammographic Density Phenotypes & Breast Cancer

Andrew H. Beck, S. Cummings, C. Vachon, 2015 .

Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer-Clinical Notice

Anthony Rhodes, Paul Valenstein, Daniel F. Hayes, 2010 .

Centrally Necrotizing Carcinomas of the Breast: A Distinct Histologic Subtype With Aggressive Clinical Behavior

D. Visscher, R. Jimenez, T. Wallis, 2001, The American journal of surgical pathology.

Sclerosing adenosis and risk of breast cancer

R. Vierkant, D. Radisky, L. Hartmann, 2014, Breast Cancer Research and Treatment.

Clinicopathologic analysis of bcl-2 immunostaining in breast carcinoma.

F. Sarkar, D. Visscher, J. Crissman, 1996, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.

Correlation of tumor volume and surface area with lymph node status in patients with multifocal/multicentric breast carcinoma

David Bouwman, D. Visscher, A. Andea, 2004, Cancer.

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer

Krishna R. Kalari, Victoria L. Cafourek, F. Couch, 2017, Breast Cancer Research and Treatment.

Detection of chromosome aneuploidy in breast lesions with fluorescence in situ hybridization: comparison of whole nuclei to thin tissue sections and correlation with flow cytometric DNA analysis.

D. Visscher, T. Wallis, C. A. Ritchie, 1995, Cytometry.

NanoString-based breast cancer risk prediction for women with sclerosing adenosis

R. Vierkant, C. Vachon, D. Radisky, 2017, Breast Cancer Research and Treatment.

Immunohistologic Analysis of Estrogen Receptor Expression in Breast Carcinoma Precursor Lesions

D. Long, D. Visscher, P. Tabaczka, 1998 .

Intraoperative frozen section analysis of margins in breast conserving surgery significantly decreases reoperative rates: one-year experience at an ambulatory surgical center.

Jeffrey L Myers, Patrick Healy, Julie M Jorns, 2012, American journal of clinical pathology.

Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics

S. Cummings, C. Vachon, C. Scott, 2018, Breast Cancer Research and Treatment.

Flow cytometric DNA and clinicopathologic analysis of Dukes' A&B colonic adenocarcinomas: a retrospective study.

C. Ma, D. Visscher, R. Zarbo, 1990, Modern Pathology.

Circulating Sex Hormones and Terminal Duct Lobular Unit Involution of the Normal Breast

Jesus J. Caban, Gretchen L. Gierach, M. Sherman, 2014, Cancer Epidemiology, Biomarkers & Prevention.

Edinburgh Research Explorer Association between breast cancer genetic susceptibility variants and terminal duct lobular unit involution of the breast

Gretchen L. Gierach, S. Chanock, M. García-Closas, 2022 .

Folate receptor alpha expression associates with improved disease-free survival in triple negative breast cancer patients

Krishna R. Kalari, F. Couch, B. Necela, 2020, npj Breast Cancer.

Histologic and Radiographic Analysis of Ductal Carcinoma In Situ Diagnosed Using Stereotactic Incisional Core Breast Biopsy

D. Visscher, N. Pernick, T. Wallis, 2002, Modern Pathology.

Clinicopathologic significance of ductal carcinoma in situ in breast core needle biopsies with invasive cancer.

D. Visscher, R. Jimenez, D. Bouwman, 2000, The American journal of surgical pathology.

Rad 6 Overexpression Induces Multinucleation , Centrosome Amplification , Abnormal Mitosis , Aneuploidy , and Transformation 1

H. Heng, D. Visscher, A. Lyakhovich, 2002 .

Image cytophotometric DNA histogram heterogeneity in adenocarcinoma of the breast.

D. Visscher, J. Crissman, S. Drozdowicz, 1993, Analytical and quantitative cytology and histology.

Histopathologic Evidence of Tumor Regression in the Axillary Lymph Nodes of Patients Treated With Preoperative Chemotherapy Correlates With Breast Cancer Outcome

L. Newman, D. Visscher, V. Adsay, 2003, Annals of Surgical Oncology.

Estrogen receptor expression is high but is of lower intensity in tubular carcinoma than in well-differentiated invasive ductal carcinoma.

E. Mardis, M. Ellis, T. Vickery, 2014, Archives of pathology & laboratory medicine.

Clinicopathologic features of breast cancers that develop in women with previous benign breast disease

R. Vierkant, C. Vachon, KathleenR. Brandt, 2016, Cancer.

Analysis of DNA methylation in endometrial biopsies to predict risk of endometrial cancer.

Joseph D. Madison, M. Sherman, D. Visscher, 2020, Gynecologic oncology.

Gene signature model for breast cancer risk prediction for women with sclerosing adenosis

R. Vierkant, D. Radisky, A. Oberg, 2015, Breast Cancer Research and Treatment.

Mammographic breast density and risk of breast cancer in women with atypical hyperplasia: an observational cohort study from the Mayo Clinic Benign Breast Disease (BBD) cohort

R. Vierkant, C. Vachon, C. Scott, 2017, BMC Cancer.

Case report 472

D. Visscher, R. Alexander, T. R. Dempsey, 2004, Skeletal Radiology.

Antiintegrin av,83 blocks human breast cancer growth and angiogenesis in human skin

F. Sarkar, D. Visscher, R. Klemke, 2013 .

Editorial comments: C‐ERBB‐2 in Retrospect: Is it time for molecular cytology?

D. Visscher, C. Bedrossian, 1995 .

Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast

S. Chanock, M. García-Closas, D. Visscher, 2020, npj Breast Cancer.

Polygenic risk score for the prediction of breast cancer is related to lesser terminal duct lobular unit involution of the breast

Gretchen L. Gierach, S. Chanock, M. García-Closas, 2020, npj Breast Cancer.

Clinicopathologic analysis of microscopically invasive breast carcinoma.

D. Visscher, R. Jimenez, 1998, Human pathology.

The inflammatory microenvironment in epithelial ovarian cancer: a role for TLR4 and MyD88 and related proteins

R. Vierkant, E. Goode, D. Visscher, 2016, Tumor Biology.

Evaluation of Chromosome 12 Copy Number in Ovarian Granulosa Cell Tumors Using Interphase Cytogenetics

D. Visscher, W. Lawrence, Dorothy Halperin, 1995, International journal of gynecological pathology : official journal of the International Society of Gynecological Pathologists.

Body mass index, mammographic density, and breast cancer risk by estrogen receptor subtype

C. Vachon, C. Scott, K. Brandt, 2019, Breast Cancer Research.

Association between mammographic breast density and histologic features of benign breast disease

R. Vierkant, C. Vachon, C. Scott, 2017, Breast Cancer Research.

Utility of DNA postreplication repair protein Rad6B in neoadjuvant chemotherapy response

D. Visscher, J. Abrams, M. Shekhar, 2010, Medical oncology.

Tissue-based associations of mammographic breast density with breast stem cell markers

C. Vachon, C. Scott, K. Brandt, 2017, Breast Cancer Research.

Assessment of published models and prognostic variables in epithelial ovarian cancer at Mayo Clinic

E. Goode, A. Oberg, L. Hartmann, 2015, Gynecologic oncology.

Breast fibroadenomas are not associated with increased breast cancer risk in an African American contemporary cohort of women with benign breast disease

D. Visscher, J. Ruterbusch, S. Bandyopadhyay, 2018, Breast Cancer Research.

Breast Cancer Risk and Progressive Histology in Serial Benign Biopsies

R. Vierkant, D. Radisky, L. Hartmann, 2017, Journal of the National Cancer Institute.

A Universal Method for the Mutational Analysis of K-ras and p53 Gene in Non‐small-cell Lung Cancer Using Formalin‐Fixed Paraffin‐Embedded Tissue

F. Sarkar, D. Visscher, J. Crissman, 1995, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

Abstract PD1-08: Frequency, characteristics and prognostic factors of PD-L1+ triple negative breast cancer using the PD-L1 SP142 companion assay

Krishna R. Kalari, F. Couch, K. Kalari, 2020 .

Influence of tumor site on the therapy of murine kidney cancer.

G. Haas, D. Visscher, J. Pontes, 1994, Anticancer Research.

American society of clinical oncology/college of american pathologists guideline recommendations for immunohistochemical testing of estrogen and progesterone receptors in breast cancer.

M. Dowsett, D. Visscher, M. Hammond, 2010, Journal of oncology practice.

Ovarian cancer tumorgraft: Viral latency propagates lymphoma

D. Visscher, S. Weroha, P. Haluska, 2012 .

Postlactational involution biomarkers plasminogen and phospho-STAT3 are linked with active age-related lobular involution

R. Vierkant, D. Radisky, L. Hartmann, 2017, Breast Cancer Research and Treatment.

Correlation of DNA ploidy with c-erbB-2 expression in preinvasive and invasive breast tumors.

F. Sarkar, D. Visscher, J. Crissman, 1991, Analytical and quantitative cytology and histology.

Theory and methodology of evaluating genetic alterations

F. Sarkar, D. Visscher, S. Wolman, 1994, Diagnostic cytopathology.

HISTOLOGIC AND IMMUNOPHENOTYPIC EVALUATION OF PRETREATMENT RENAL BIOPSIES IN OKT3‐TREATED ALLOGRAFT REJECTIONS

D. Visscher, R. Zarbo, W. Kupin, 1991, Transplantation.

Abstract 2364: CD68+ immune cells show different infiltration patterns in tissue samples from women with no clinical breast disease and those who have benign breast disease

D. Radisky, A. Degnim, D. Visscher, 2015 .

Phospholipase C‐γ Immunostaining in Human Breast Carcinoma: Clinical Significance and Correlations with Protease and Growth‐Factor Receptor Species

M. Banerjee, F. Sarkar, D. Visscher, 1997 .

Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer: The Women’s Health Study: A Randomized Controlled Trial

J. Manson, R. Vierkant, T. Sellers, 2005, JAMA.

Angiogenesis in breast carcinoma--clinicopathologic relevance and potential use as a quantifiable surrogate endpoint biomarker.

D. Visscher, W. Lawrence, S. Boman, 1994, Journal of cellular biochemistry. Supplement.

Matrix Metalloproteinase Induction of Rac1b, a Key Effector of Lung Cancer Progression

D. Radisky, D. Visscher, G. Downey, 2012, Science Translational Medicine.

Biomarker-Based Ovarian Carcinoma Typing: A Histologic Investigation in the Ovarian Tumor Tissue Analysis Consortium

R. Vierkant, B. Fridley, E. Goode, 2013, Cancer Epidemiology, Biomarkers & Prevention.

Abstract 4465: Breast cancer risk factor associations with breast tissue morphometry: results from the Komen for the Cure® Tissue Bank

Gretchen L. Gierach, M. Sherman, D. Visscher, 2012 .

Mammographic density and risk of breast cancer by age and tumor characteristics

Andrew H. Beck, S. Cummings, C. Vachon, 2013, Breast Cancer Research.

Sequential versus concurrent trastuzumab in adjuvant chemotherapy for breast cancer.

E. Perez, D. Visscher, J. Ingle, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Model for Predicting Breast Cancer Risk in Women With Atypical Hyperplasia.

R. Vierkant, C. Vachon, V. Pankratz, 2015, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Management of Benign Intraductal Solitary Papilloma Diagnosed on Core Needle Biopsy

D. Visscher, C. Reynolds, K. Glazebrook, 2013, Annals of Surgical Oncology.

A phase I trial of the safety and immunogenicity of a multi-epitope folate receptor alpha peptide vaccine used in combination with cyclophosphamide in subjects previously treated for breast or ovarian cancer.

D. Visscher, V. Suman, T. Hobday, 2015 .

Impact of histopathology, tumor-infiltrating lymphocytes, and adjuvant chemotherapy on prognosis of triple-negative breast cancer

Krishna R. Kalari, Victoria L. Cafourek, F. Couch, 2017, Breast Cancer Research and Treatment.

Assessment of folate receptor-β expression in human neoplastic tissues

P. Low, D. Dimitrov, D. Visscher, 2015, Oncotarget.

c-erbB-2 promoter-specific DNA-binding protein isolated from human breast cancer tissues displays mitogenic activity.

F. Sarkar, D. Longo, D. Visscher, 1994, The Journal of biological chemistry.